Diagnosis and management of rheumatic immune- related adverse events due to cancer immunotherapy with checkpoint inhibitors - EULAR | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
EULAR
2020
·
Europe
·
Rheumatology
Diagnosis and management of rheumatic immune- related adverse events due to cancer immunotherapy with checkpoint inhibitors
Document
Analyser ce document
